|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2006-11-28
|
|
pubmed:abstractText |
Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--could be an alternative to heparins and warfarin for the prevention and treatment of thromboembolic disorders.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BorrisLars CLC,
pubmed-author:DahlOla EOE,
pubmed-author:DierigChristophC,
pubmed-author:ErikssonBengt IBI,
pubmed-author:HaasSylviaS,
pubmed-author:HuismanMenno VMV,
pubmed-author:KäleboPeterP,
pubmed-author:KakkarAjay KAK,
pubmed-author:MisselwitzFrankF,
pubmed-author:MuehlhoferEvaE,
pubmed-author:ODIXa-HIP Study Investigators
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
28
|
|
pubmed:volume |
114
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2374-81
|
|
pubmed:dateRevised |
2009-2-10
|
|
pubmed:meshHeading |
pubmed-meshheading:17116766-Administration, Oral,
pubmed-meshheading:17116766-Adult,
pubmed-meshheading:17116766-Anticoagulants,
pubmed-meshheading:17116766-Arthroplasty, Replacement, Hip,
pubmed-meshheading:17116766-Double-Blind Method,
pubmed-meshheading:17116766-Drug Administration Schedule,
pubmed-meshheading:17116766-Factor Xa,
pubmed-meshheading:17116766-Female,
pubmed-meshheading:17116766-Hemorrhage,
pubmed-meshheading:17116766-Humans,
pubmed-meshheading:17116766-Male,
pubmed-meshheading:17116766-Middle Aged,
pubmed-meshheading:17116766-Morpholines,
pubmed-meshheading:17116766-Postmenopause,
pubmed-meshheading:17116766-Postoperative Complications,
pubmed-meshheading:17116766-Safety,
pubmed-meshheading:17116766-Sample Size,
pubmed-meshheading:17116766-Survival Analysis,
pubmed-meshheading:17116766-Thiophenes
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
|
|
pubmed:affiliation |
Department of Orthopaedics, Sahlgrenska University Hospital/Ostra, SE-416 85 Gothenburg, Sweden. b.eriksson@orthop.gu.se
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
